Metastatic Colorectal Cancers Recruiting Phase 2 Trials for Avelumab (DB11945)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03186326Standard Chemotherapy vs Immunotherapie in 2nd Line Treatment of MSI Colorectal Mestastatic CancerTreatment
NCT03150706Avelumab for MSI-H or POLE Mutated Metastatic Colorectal CancerTreatment